Citi Starts Larimar Therapeutics (LRMR) at Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/12/2026

1. CRWV
2. SMCI
3. GAMI
4. LITE
5. ONON
6. SPY
7. CAVA
8. CSCO
9. USO
10. NTHI

December 13, 2022 5:06 AM EST
Get Alerts LRMR Hot Sheet
Price: $4.37 +1.39%

Rating Summary:
    12 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE

Citi analyst Samantha Semenkow initiates coverage on Larimar Therapeutics (NASDAQ: LRMR) with a Neutral rating and a price target of $4.00.


For an analyst ratings summary and ratings history on Larimar Therapeutics click here. For more ratings news on Larimar Therapeutics click here.


Shares of Larimar Therapeutics closed at $3.89 yesterday.


You May Also Be Interested In





Related Categories

New Coverage